These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 9578686
1. [Morphological changes induced by valproate and its administration concomitant with folinic acid or S-adenosylmethionine in pregnant rats]. Ubeda-Martín N, Alonso-Aperte E, Achón M, Varela-Moreiras G, Puerta J, Pérez de Miguelsanz J. Nutr Hosp; 1998; 13(1):41-9. PubMed ID: 9578686 [Abstract] [Full Text] [Related]
2. Valproate-induced developmental modifications maybe partially prevented by coadministration of folinic acid and S-adenosylmethionine. Ubeda N, Alonso E, Martín-Rodríguez JC, Varela-Moreiras G, Puerta J, Pérez-Miguelsanz J. Int J Dev Biol; 1996; Suppl 1():291S-292S. PubMed ID: 9087803 [No Abstract] [Full Text] [Related]
3. VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione. Hishida R, Nau H. Teratog Carcinog Mutagen; 1998; 18(2):49-61. PubMed ID: 9704382 [Abstract] [Full Text] [Related]
4. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice. Dawson JE, Raymond AM, Winn LM. Toxicol Appl Pharmacol; 2006 Mar 01; 211(2):124-32. PubMed ID: 16112698 [Abstract] [Full Text] [Related]
5. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation. Padmanabhan R, Shafiullah MM. Congenit Anom (Kyoto); 2003 Mar 01; 43(1):29-40. PubMed ID: 12692401 [Abstract] [Full Text] [Related]
6. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term. Menegola E, Broccia ML, Nau H, Prati M, Ricolfi R, Giavini E. Teratog Carcinog Mutagen; 1996 Mar 01; 16(2):97-108. PubMed ID: 8875740 [Abstract] [Full Text] [Related]
10. Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation. Alonso-Aperte E, Ubeda N, Achón M, Pérez-Miguelsanz J, Varela-Moreiras G. Neurology; 1999 Mar 10; 52(4):750-6. PubMed ID: 10078722 [Abstract] [Full Text] [Related]
11. Lack of attenuation of valproic acid-induced effects by folinic acid in rat embryos in vitro. Hansen DK, Grafton TF. Teratology; 1991 Jun 10; 43(6):575-82. PubMed ID: 1882348 [Abstract] [Full Text] [Related]
12. Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Ornoy A. Reprod Toxicol; 2009 Jul 10; 28(1):1-10. PubMed ID: 19490988 [Abstract] [Full Text] [Related]
13. Amidic modification of valproic acid reduces skeletal teratogenicity in mice. Okada A, Kurihara H, Aoki Y, Bialer M, Fujiwara M. Birth Defects Res B Dev Reprod Toxicol; 2004 Feb 10; 71(1):47-53. PubMed ID: 14991910 [Abstract] [Full Text] [Related]
16. Folic acid and methionine in the prevention of teratogen-induced congenital defects in mice. Cipollone D, Carsetti R, Tagliani A, Rosado MM, Borgiani P, Novelli G, D'Amati G, Fumagalli L, Marino B, Businaro R. Cardiovasc Pathol; 2009 Feb 10; 18(2):100-9. PubMed ID: 18417366 [Abstract] [Full Text] [Related]
17. Myo-inositol enhances teratogenicity of valproic acid in the mouse. Massa V, Wlodarczyk B, Giavini E, Finnell RH. Birth Defects Res A Clin Mol Teratol; 2006 Mar 10; 76(3):200-4. PubMed ID: 16511884 [Abstract] [Full Text] [Related]